查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386152

疟疾疫苗市场报告：2030 年趋势、预测与竞争分析

Malaria Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

疟疾疫苗趋势与预测

预计到 2030 年，全球疟疾疫苗市场将达到 69 亿美元，2024 年至 2030 年复合年增长率为 18.6%。该市场的主要驱动力是对疟疾疫苗的需求不断增长、前红血球生成疫苗的出现以及对疫苗输送平台的日益偏好。全球疟疾疫苗市场前景看好，医院、专科诊所和居家医疗市场都有商机。

疟疾疫苗市场洞察

Lucintel 预测，在预测期内，前红系细胞预计将经历最高的增长。

在这个市场中，预计医院将在预测期内实现最高成长。

由于其强大的医疗基础设施、疫苗研发的高投资以及主要製造商的存在，北美仍然是最大的地区。

市场规模/估计：以金额的估计疟疾疫苗市场规模（10 亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

細項分析：按类型、药物、最终用途和地区金额（十亿美元）估计疟疾疫苗市场规模。

区域分析：北美、欧洲、亚太地区以及世界其他地区、中东和非洲的疟疾疫苗市场细分。

成长机会：按类型、药物、最终用途和地区分類的疟疾疫苗市场成长机会分析。

策略分析：疟疾疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球疟疾疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球疟疾疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 全球疟疾疫苗市场（按类型）
    • 前红血球
    • 红血球
    • 多种抗原
    • 其他的
  • 按药物分類的全球疟疾疫苗市场
    • 恶性疟原虫
    • 间日疟原虫
    • 按蚊种
  • 全球疟疾疫苗市场（依最终用途）
    • 医院
    • 专科诊所
    • 居家医疗
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球疟疾疫苗市场区域分布
  • 北美疟疾疫苗市场
  • 欧洲疟疾疫苗市场
  • 亚太疟疾疫苗市场
  • 其他区域疟疾疫苗市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球疟疾疫苗市场成长机会
    • 全球疟疾疫苗市场药物成长机会
    • 全球疟疾疫苗市场成长机会（依最终用途）
    • 全球疟疾疫苗市场成长机会（按地区）
  • 全球疟疾疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球疟疾疫苗市场产能扩张
    • 全球疟疾疫苗市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Actiza Pharmaceutical
  • AdvaCare Pharma
  • Ipca Laboratories
  • Bliss GVS Pharma
  • GeoVax
  • Sumaya Biotech
  • VLP Therapeutics
  • OSIVAX
  • AJANTA PHARMA
  • Strides Pharma Science
简介目录

Malaria Vaccine Trends and Forecast

The future of the global malaria vaccine market looks promising with opportunities in the hospital, specialty clinic, and homecare markets. The global malaria vaccine market is expected to reach an estimated $6.9 billion by 2030 with a CAGR of 18.6% from 2024 to 2030. The major drivers for this market are growing demand for malaria vaccines, emergence of pre-erythrocytic vaccines, and rising preference for vaccine delivery platforms.

A more than 150-page report is developed to help in your business decisions.

Malaria Vaccine by Segment

The study includes a forecast for the global malaria vaccine by type, agent, end use, and region.

Malaria Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Pre-Erythrocytic
  • Erythrocytic
  • Multi-Antigen
  • Others

Malaria Vaccine Market by Agent [Shipment Analysis by Value from 2018 to 2030]:

  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Anopheles Species

Malaria Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Malaria Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Malaria Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies malaria vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the malaria vaccine companies profiled in this report include-

  • Actiza Pharmaceutical
  • AdvaCare Pharma
  • Ipca Laboratories
  • Bliss GVS Pharma
  • GeoVax
  • Sumaya Biotech
  • VLP Therapeutics
  • OSIVAX
  • AJANTA PHARMA
  • Strides Pharma Science

Malaria Vaccine Market Insights

Lucintel forecasts that pre-erythrocytic is expected to witness highest growth over the forecast period.

Within this market, hospital is expected to witness highest growth over the forecast period.

North America will remain the largest region due to existence of robust healthcare infrastructure, high investment in vaccines research and development, and presence of key manufacturers in the region.

Features of the Global Malaria Vaccine Market

Market Size Estimates: Malaria vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Malaria vaccine market size by type, agent, end use, and region in terms of value ($B).

Regional Analysis: Malaria vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, agents, end uses, and regions for the malaria vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the malaria vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the malaria vaccine market size?

Answer: The global malaria vaccine market is expected to reach an estimated $6.9 billion by 2030.

Q.2 What is the growth forecast for malaria vaccine market?

Answer: The global malaria vaccine market is expected to grow with a CAGR of 18.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the malaria vaccine market?

Answer: The major drivers for this market are growing demand for malaria vaccines, emergence of pre-erythrocytic vaccines, and rising preference for vaccine delivery platforms.

Q4. What are the major segments for malaria vaccine market?

Answer: The future of the malaria vaccine market looks promising with opportunities in the hospital, specialty clinic, and homecare markets.

Q5. Who are the key malaria vaccine market companies?

Answer: Some of the key malaria vaccine companies are as follows:

  • Actiza Pharmaceutical
  • AdvaCare Pharma
  • Ipca Laboratories
  • Bliss GVS Pharma
  • GeoVax
  • Sumaya Biotech
  • VLP Therapeutics
  • OSIVAX
  • AJANTA PHARMA
  • Strides Pharma Science

Q6. Which malaria vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that pre-erythrocytic is expected to witness highest growth over the forecast period.

Q7. In malaria vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, high investment in vaccines research and development, and presence of key manufacturers in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the malaria vaccine market by type (pre-erythrocytic, erythrocytic, multi-antigen, and others), agent (plasmodium falciparum, plasmodium vivax, and anopheles species), end use (hospitals, specialty clinics, homecare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Malaria Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Malaria Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Malaria Vaccine Market by Type
    • 3.3.1: Pre-Erythrocytic
    • 3.3.2: Erythrocytic
    • 3.3.3: Multi-Antigen
    • 3.3.4: Others
  • 3.4: Global Malaria Vaccine Market by Agent
    • 3.4.1: Plasmodium Falciparum
    • 3.4.2: Plasmodium Vivax
    • 3.4.3: Anopheles Species
  • 3.5: Global Malaria Vaccine Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Homecare
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Malaria Vaccine Market by Region
  • 4.2: North American Malaria Vaccine Market
    • 4.2.2: North American Malaria Vaccine Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others
  • 4.3: European Malaria Vaccine Market
    • 4.3.1: European Malaria Vaccine Market by Type: Pre-Erythrocytic, Erythrocytic, Multi-Antigen, and Others
    • 4.3.2: European Malaria Vaccine Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others
  • 4.4: APAC Malaria Vaccine Market
    • 4.4.1: APAC Malaria Vaccine Market by Type: Pre-Erythrocytic, Erythrocytic, Multi-Antigen, and Others
    • 4.4.2: APAC Malaria Vaccine Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others
  • 4.5: ROW Malaria Vaccine Market
    • 4.5.1: ROW Malaria Vaccine Market by Type: Pre-Erythrocytic, Erythrocytic, Multi-Antigen, and Others
    • 4.5.2: ROW Malaria Vaccine Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Malaria Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Malaria Vaccine Market by Agent
    • 6.1.3: Growth Opportunities for the Global Malaria Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Malaria Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Malaria Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Malaria Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Malaria Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Actiza Pharmaceutical
  • 7.2: AdvaCare Pharma
  • 7.3: Ipca Laboratories
  • 7.4: Bliss GVS Pharma
  • 7.5: GeoVax
  • 7.6: Sumaya Biotech
  • 7.7: VLP Therapeutics
  • 7.8: OSIVAX
  • 7.9: AJANTA PHARMA
  • 7.10: Strides Pharma Science